Intriguingly, investigations have been made into RIPK3's surprising role in boosting malignant proliferation and encouraging the production of proinflammatory mediators [91], implicating that these molecules may have different expression levels in IBD and colitis-associated cancer (CAC) (Table 2). The gene discussed is RIPK3; the disease is inflammatory bowel disease.